VolitionRX Ltd Company Profile (NYSEMKT:VNRX)

About VolitionRX Ltd

VolitionRX Ltd logoVolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: VNRX
  • CUSIP:
Key Metrics:
  • Previous Close: $4.36
  • 50 Day Moving Average: $4.45
  • 200 Day Moving Average: $4.43
  • 52-Week Range: $3.05 - $5.86
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.79
  • P/E Growth: 0.00
  • Market Cap: $113.77M
  • Outstanding Shares: 26,093,000
  • Beta: -1.58
Additional Links:
Companies Related to VolitionRX Ltd:

Analyst Ratings

Consensus Ratings for VolitionRX Ltd (NYSEMKT:VNRX) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00

Analysts' Ratings History for VolitionRX Ltd (NYSEMKT:VNRX)
DateFirmActionRatingPrice TargetDetails
9/8/2016HC WainwrightSet Price TargetBuy$10.00View Rating Details
9/7/2016Rodman & RenshawLower Price TargetBuy$12.00 -> $10.00View Rating Details
3/25/2015Benchmark Co.Initiated CoverageBuy$10.00View Rating Details
(Data available from 2/26/2015 forward)


Earnings History for VolitionRX Ltd (NYSEMKT:VNRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q216($0.12)($0.13)ViewListenView Earnings Details
5/13/2016Q116($0.13)($0.13)ViewN/AView Earnings Details
11/4/2015Q315($0.13)($0.16)ViewN/AView Earnings Details
8/11/2015Q215($0.14)($0.10)ViewN/AView Earnings Details
5/12/2015Q115($0.14)($0.12)ViewN/AView Earnings Details
12/17/2014($0.09)($0.13)ViewN/AView Earnings Details
5/27/2014($0.10)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for VolitionRX Ltd (NYSEMKT:VNRX)
Current Year EPS Consensus Estimate: $-0.56 EPS
Next Year EPS Consensus Estimate: $-0.56 EPS


Dividend History for VolitionRX Ltd (NYSEMKT:VNRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for VolitionRX Ltd (NYSEMKT:VNRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/5/2016David Matthew KratochvilCFOBuy10,000$5.00$50,000.00View SEC Filing  
5/20/2016Cameron John ReynoldsCEOSell3,390$3.54$12,000.60View SEC Filing  
5/15/2015Cameron John ReynoldsCEOBuy1,500$3.33$4,995.00View SEC Filing  
2/11/2015Guy Archibald InnesDirectorBuy50,000$3.75$187,500.00View SEC Filing  
9/15/2014Martin Charles FaulkesDirectorBuy5,000$2.16$10,800.00View SEC Filing  
9/3/2014Rodney Gerard RootsaertInsiderSell28,000$1.80$50,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for VolitionRX Ltd (NYSEMKT:VNRX)
us.rd.yahoo.com logoVolitionRx Limited's Triage Test Results Validated in Prospective Trial (NYSEMKT:VNRX)
us.rd.yahoo.com - February 25 at 8:05 PM
4-traders.com logoVolitionRx : Triage Test Results Validated in Prospective Trial (NYSEMKT:VNRX)
www.4-traders.com - February 24 at 9:19 AM
finance.yahoo.com logoVolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference (NYSEMKT:VNRX)
finance.yahoo.com - February 23 at 11:43 PM
News IconVolitionRX Ltd VNRX Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250 (NYSEMKT:VNRX)
www.bioportfolio.com - February 22 at 11:13 AM
News IconVolitionRX Ltd VNRX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NYSEMKT:VNRX)
www.bioportfolio.com - February 19 at 7:28 PM
finance.yahoo.com logoVolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017 (NYSEMKT:VNRX)
finance.yahoo.com - February 10 at 6:31 AM
finance.yahoo.com logo2 Medical Companies at Forefront of Oncology Testing (NYSEMKT:VNRX)
finance.yahoo.com - January 8 at 6:32 AM
finance.yahoo.com logoVolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia (NYSEMKT:VNRX)
finance.yahoo.com - January 6 at 6:31 AM
investors.com logoVolitionRx shares gain on Buy recommendation, Ritter initiated at Buy too (NYSEMKT:VNRX)
www.proactiveinvestors.com - January 4 at 4:16 PM
finance.yahoo.com logoVNRX: Triage CE Marked. More Details Next Week at JPM Conference (NYSEMKT:VNRX)
finance.yahoo.com - January 4 at 4:16 PM
us.rd.yahoo.com logoVolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe (NYSEMKT:VNRX)
us.rd.yahoo.com - January 4 at 7:38 AM
us.rd.yahoo.com logo9:03 am VolitionRx achieved CE marking on its Nu.Q Colorectal Cancer Screening Triage Test on December 28, 2016 as it prepares to launch across Europe (NYSEMKT:VNRX)
us.rd.yahoo.com - January 4 at 7:38 AM
4-traders.com logoVolitionRx : to Present at 9th Annual Biotech Showcase Conference (NYSEMKT:VNRX)
www.4-traders.com - December 29 at 11:10 PM
finance.yahoo.com logoVolitionRx Limited to Present at 9th Annual Biotech Showcase Conference (NYSEMKT:VNRX)
finance.yahoo.com - December 28 at 8:20 AM
News IconNew Report Available: VolitionRX Ltd. (VNRX) - Financial and Strategic SWOT Analysis Review (NYSEMKT:VNRX)
reports.pr-inside.com - December 2 at 9:57 AM
capitalcube.com logoVolitionRX Ltd. :VNRX-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 (NYSEMKT:VNRX)
www.capitalcube.com - December 1 at 9:15 PM
finance.yahoo.com logoVolitionRx Limited to Attend Citi 2016 Global Healthcare Conference (NYSEMKT:VNRX)
finance.yahoo.com - December 1 at 9:15 PM
finance.yahoo.com logoVNRX: More Details on Triage Strategy, Launch Still Expected in 2017 (NYSEMKT:VNRX)
finance.yahoo.com - November 18 at 11:46 AM
4-traders.com logoVolitionRx : VNRX) Files An 8-K Results of Operations and Financial Condition (NYSEMKT:VNRX)
www.4-traders.com - November 16 at 8:32 PM
4-traders.com logoVolitionRx : to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016 (NYSEMKT:VNRX)
www.4-traders.com - November 11 at 11:28 AM
finance.yahoo.com logoVolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016 (NYSEMKT:VNRX)
finance.yahoo.com - November 11 at 11:28 AM
sg.finance.yahoo.com logoVolitionRX reports 3Q loss (NYSEMKT:VNRX)
sg.finance.yahoo.com - November 10 at 11:57 AM
finance.yahoo.com logoVolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update (NYSEMKT:VNRX)
finance.yahoo.com - November 4 at 12:26 PM
investors.com logoVolitionRx outgrows its old R&D facilities (NYSEMKT:VNRX)
www.proactiveinvestors.com - October 26 at 11:47 AM
finance.yahoo.com logoVolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition (NYSEMKT:VNRX)
finance.yahoo.com - October 26 at 11:47 AM
investors.com logoVolitionRx says underwriter exercises over-allotment option (NYSEMKT:VNRX)
www.proactiveinvestors.com - October 21 at 7:59 PM
finance.yahoo.com logoVolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter (NYSEMKT:VNRX)
finance.yahoo.com - October 21 at 11:40 AM
prnewswire.com logoTriage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee (NYSEMKT:VNRX)
www.prnewswire.com - October 17 at 7:52 PM
finance.yahoo.com logoSeeThruEquity Issues Update on VolitionRX (VNRX) and Raises Price Target to $7.00 (NYSEMKT:VNRX)
finance.yahoo.com - October 13 at 12:01 PM
streetinsider.com logoVolitionrx Limited (VNRX) Announces Presentation of Positive Blood Test for Colorectal Cancer Data (NYSEMKT:VNRX)
www.streetinsider.com - October 12 at 12:56 PM
investors.com logoVolitionRx says test can slash colorectal cancer 'false positives' (NYSEMKT:VNRX)
www.proactiveinvestors.com - October 12 at 12:56 PM
finance.yahoo.com logoVolitionRX Ltd. to Present at The MicroCap Conference on October 24-25 in Philadelphia (NYSEMKT:VNRX)
finance.yahoo.com - October 11 at 7:46 PM
biz.yahoo.com logoVOLITIONRX LTD Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Mat (NYSEMKT:VNRX)
biz.yahoo.com - October 11 at 7:46 PM
investors.com logoVolitionRx Ltd set for US$10.6mln cash boost after placing (NYSEMKT:VNRX)
www.proactiveinvestors.com - October 6 at 7:44 PM
investors.com logoVolitionRx announces pricing of public offer of stock (NYSEMKT:VNRX)
www.proactiveinvestors.com - October 3 at 7:25 PM
fxpips.com logoStocks Gapping Down – GPIC, DWSN, AEHR, DCTH, VNRX, ADHD, VEC (NYSEMKT:VNRX)
www.fxpips.com - October 3 at 7:52 AM
prnewswire.com logoVolitionRx Limited Announces Pricing of Public Offering of Common Stock (NYSEMKT:VNRX)
www.prnewswire.com - October 1 at 8:45 AM
investors.com logoVolitionRX prices share offer at US$5 a pop (NYSEMKT:VNRX)
www.proactiveinvestors.com - September 30 at 7:13 PM
finance.yahoo.com logoVolitionRx Limited Announces Proposed Public Offering of Common Stock (NYSEMKT:VNRX)
finance.yahoo.com - September 30 at 7:28 AM
investing.com logoVolitionRX: First Product Ready To Enter Market (NYSEMKT:VNRX)
www.investing.com - September 23 at 7:21 PM
finance.yahoo.com logoVNRX: Initial Product Will Be Complement To Current CRC Screens (NYSEMKT:VNRX)
finance.yahoo.com - September 7 at 8:04 PM
finance.yahoo.com logoVolitionRx to Attend Several Conferences in September (NYSEMKT:VNRX)
finance.yahoo.com - September 7 at 11:52 AM
finance.yahoo.com logoVolition's Nu.Q Triage Colorectal Cancer Screening Test Expected to Reduce Colonoscopy Referral by 25 Percent (NYSEMKT:VNRX)
finance.yahoo.com - September 6 at 7:04 AM
fxpips.com logoManufacturing Stocks Daily Winners, Losers, Sept. 5 (NYSEMKT:VNRX)
www.fxpips.com - September 5 at 7:04 AM
finance.yahoo.com logoVolitionRx Schedules Product Launch Update Conference Call for Tuesday, September 6, 2016 at 8:30 am ET (NYSEMKT:VNRX)
finance.yahoo.com - September 1 at 11:19 AM
finance.yahoo.com logoVNRX: E.U. Launch Expected Early 2017. More Details in Sept / Oct (NYSEMKT:VNRX)
finance.yahoo.com - August 15 at 8:32 PM
News IconJust Published: "Offshore Investments Scenario of India: Investments Analytics" (NYSEMKT:VNRX)
reports.pr-inside.com - August 11 at 11:37 AM
News IconVolitionRx Announces Second Quarter 2016 Financial Results and Business Update (NYSEMKT:VNRX)
ih.advfn.com - August 11 at 11:37 AM
sg.finance.yahoo.com logoVolitionRX reports 2Q loss (NYSEMKT:VNRX)
sg.finance.yahoo.com - August 11 at 11:37 AM
benzinga.com logoVolitionRx Schedules Second Quarter 2016 Earnings... (NYSEMKT:VNRX)
www.benzinga.com - August 8 at 7:13 AM


What is VolitionRX Ltd's stock symbol?

VolitionRX Ltd trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "VNRX."

Where is VolitionRX Ltd's stock going? Where will VolitionRX Ltd's stock price be in 2017?

2 analysts have issued 1 year price targets for VolitionRX Ltd's stock. Their forecasts range from $10.00 to $10.00. On average, they expect VolitionRX Ltd's share price to reach $10.00 in the next year.

When will VolitionRX Ltd announce their earnings?

VolitionRX Ltd is scheduled to release their next quarterly earnings announcement on Thursday, March, 9th 2017.

Who owns VolitionRX Ltd stock?

VolitionRX Ltd's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Southpoint Capital Advisors LP (3.07%). Company insiders that own VolitionRX Ltd stock include Cameron John Reynolds and David Matthew Kratochvil.

How do I buy VolitionRX Ltd stock?

Shares of VolitionRX Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of VolitionRX Ltd stock cost?

One share of VolitionRX Ltd stock can currently be purchased for approximately $4.36.

Last Updated on 2/26/2017 by MarketBeat.com Staff